T. Rowe Price Global Value Equity continues to earn our conviction as a compelling option for investors seeking value-oriented global equities exposure. The substantially experienced and stable investment team led by Sebastian Mallet has continued to execute a differentiated and effective investment process efficiently, upholding our confidence in the strategy to deliver long-term outperformance. The strategy’s opportunistic value approach spans the value spectrum and leverages rigorous bottom-up research and effective execution. These attributes provide a robust foundation for the strategy’s ability to deliver risk-adjusted outperformance over the long term, supporting an Above Average rating for the People and Process pillars.
T. Rowe Price Global Value Equity Fund TRGVX
- NAV / 1-Day Return 24.20 / +1.07 %
- Total Assets 310.2M
-
Adj. Expense Ratio
0.890%
- Expense Ratio 0.890%
- Distribution Fee Level Average
- Share Class Type No Load
- Category Global Large-Stock Value
- Investment Style Large Blend
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 1.66%
- Turnover 77%
USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 9:00 PM GMT+0
Morningstar’s Analysis TRGVX
Will TRGVX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 23.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Microsoft Corp | 5.74 | 18M | Technology |
Alphabet Inc Class C | 3.64 | 11M | Communication Services |
JPMorgan Chase & Co | 2.15 | 7M | Financial Services |
ExxonMobil Holdings Corp | 2.11 | 7M | Energy |
Wheaton Precious Metals Corp | 1.74 | 5M | Basic Materials |
Gilead Sciences Inc | 1.70 | 5M | Healthcare |
Franco-Nevada Corp | 1.67 | 5M | Basic Materials |
Cencora Inc | 1.61 | 5M | Healthcare |
AstraZeneca PLC | 1.57 | 5M | Healthcare |
Micron Technology Inc | 1.56 | 5M | Technology |